关于 阿拉西 A9049-98-3 的 CAS 号、分子式、分子量、结构式、 COA (产品质量报告)、级别、规格、含量、熔点、性状、用途、保存、纯度、折光率、密度、沸点、库存量等,请看以下产品详细介绍! 试剂品牌: TCI 、 sigm
英文别名 OPC-7251 | 9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid 规格或纯度 10mM in DMSO 英文名称 Nadifloxacin 生化机理 纳地沙星(OPC-7251)是一种外用氟喹诺酮类抗生素,用于治疗寻常痤疮。 储存温度 -80℃储存 ...
摘要:本发明涉及生物技术领域,尤其涉及一种高效羟化4‑雄烯‑3‑酮系列化合物9α位的羟化酶及其应用,所述羟化酶氨基酸序列如SEQ ID NO:1所示,其核苷酸序列如SEQ ID NO:2所示,所述羟化酶能够生产9α‑羟基‑4‑雄烯‑3‑酮类化合物。本发明的C9α羟化酶KshA底物识别宽泛,高产9α‑羟基‑...
(4-hydroxypiperidino)-8-fluoro-4H-3a-aza-1H-phenalene-2-carboxylic acid;(5S)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;(S)-(-)-OPC-7251;(S)-9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H...
Basic Information CAS No.:26115-72-0 Name:Silane,(3-isocyanatopropyl)dimethoxymethyl Molecular Structure: Formula:C7H15 N O3 Si Molecular Weight:189.286 Synonyms:Isocyanicacid, 3-(dimethoxymethylsilyl)propyl ester (8CI);(3-Isocyanatopropyl)methyldimethoxysilane; (Methyldimethoxysilyl)propylisocyanate; ...
(Figure 2G). This is likely due to the sequence specificity of the TET2 catalytic domain, which biases its ability to protect methylated cytosines from conversion.16A possible solution to this problem would be the use of 5-hydroxymethylcytosine (5hmC, or other chemical modifications) in the ...
4-hydroxy-2,2, 6,6- tetra- mWselfofeiewttchhdtyioolnpwnsienptrheotreifoidtpnhihneooyfptloo1hc xomayttoma(clTayoEttlaiMcolyfdPtTieOccEkoLMim)nPiepsOtoiacsLsi,Otdito2hr−nie·vsedecnsyaonbvmayemneO pgi2cer−sar·zroaoafnldedeiscpoiashmlsow.etToipdhdreaeelzcyaoodklmednipodtiow...
The antiproliferative activity induced by 1α-hydroxycholecalciferol in experimental melanoma models, together with the discovery of insufficient 25-hydroxycholecalciferol serum levels in melanoma patients, provide the rationale for using vitamin D in melanoma adjuvant therapy, alone or in association with ...
(4-hydroxypiperidino)-8-fluoro-4H-3a-aza-1H-phenalene-2-carboxylic acid;(5S)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid;(S)-(-)-OPC-7251;(S)-9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H...
OPC-14117, verabreicht. Bei einer Ausführungsform der Erfindung werden die Verbindungen der Formel I in Kombination mit einem Lipoprotein-Lipase Inhibitor, wie z.B. NO-1886, verabreicht. Bei einer Ausführungsform der Erfindung werden die Verbindungen der Formel I in Kombination mit einem ...